This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 9, 2013

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

2013 ASCT Annual Conference registration is open
April 19-21, Hotel Valley Ho
American Society for Cytotechnology
   Share    Share on FacebookTwitterShare on LinkedinE-mail article
Take advantage of the new flat registration fee for lectures and workshops. Register early and secure your spot. Topics include: Advances in Telepathology, Challenging Cases During Immediate Assessment, Utility of UroVysion FISH Testing, Differential Diagnosis of Respiratory Adenocarcinoma and Squamous Carcinoma, Critical Cytology Personnel Issues, Diagnosing ASC-US and ASC-H, Quality Assurance Planning and Student Presentations.

The ASCT has secured a special hotel base rate of $169 for the nights of April 14–24, 2013, giving you a wonderful opportunity to extend your stay. Tripadvisor.com has ranked the Hotel Valley Ho as the No. 5 hotel out of 78 hotels in Scottsdale!
More




UPCOMING EVENTS





Event       Location     Dates Notes

The Evolving Role of the Cytotechnologist: Under the Microscope       Your PC    
   2 p.m. EST
   Jan. 15, 2013
   
More information
Register




INDUSTRY NEWS


CDC: Many women with hysterectomies still get unnecessary Pap tests
The Associated Press via CBS News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Many women still get screened for cervical cancer even if they have had a hysterectomy, a new study reveals. A government survey released recently shows about 60 percent of women with hysterectomies recently had a Pap test. Experts say some of the tests may have been warranted, but the others were probably done because Paps have long been part of annual doctor visits. More

Sexual revolution effect may be hiding true extent of HPV prevalence
Medwirenews via The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Human papillomavirus infection in older women is commonly due to reactivation of latent disease rather than new infection, research indicates. The study, published in The Journal of Infectious Diseases, showed that the age-specific prevalence of HPV rose with the number of sexual partners, a finding of particular relevance to women who became sexually active during the sexual revolution of the 1960s and 1970s, say the researchers. More

Cervical cancer regimen comes up short
The Courier-Journal via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
They lie in long rows of beds in a hospital women's ward — weak and forlorn as they battle cervical cancer in Kolkata, India. The plight of such women inspired a team of doctors from Louisville, Ky., and Kolkata in 2007 to explore a new treatment for the potentially deadly disease. But that team is now reaching a disappointing conclusion: An experimental radiation and immunotherapy regimen appears less effective against advanced cancer than the traditional Western treatment, which remains out of reach for many poor Indian women. More

Danish actress's death leads to spike in cancer vaccination requests
The Copenhagen Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The untimely death of Danish actress Mira Wanting due to cervical cancer has spurred women across Denmark to get the vaccination that can prevent the illness. Appointments to get the HPV vaccination, which is offered for free to women up age 27, have increased tenfold, according to DLVS, a vaccination service, since Wanting's recent death. More

MORE NEWS


World first as scientists create cancer-killing cells that can be injected
into patients

The Daily Mail    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have created cells capable of killing cancer for the first time. The dramatic breakthrough was made by researchers in Japan who created cancer-specific killer T cells. They say the development paves the way for the cells being directly injected into cancer patients for therapy. More

Novel strategies for cell-based assays
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
There are different ways to query cells. Some of these use standard light microscopy observations of dye uptake or morphology, size, adherence or mobility. Others rely on fluorescence microscopy to track labeled antibodies or reporter-driven GFP expression, or on specialized spectrophotometers to examine enzyme-driven color or light intensity changes in the culture medium. And still others make use of non-optical properties such as heat flow or electrical impedance to detect activity. More

Landmark study in blood stem cell transplant
Emory University via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Before all the excitement about embryonic stem cells, doctors were using hematopoetic — that is, blood-forming — stem cells. Hematopoetic stem cells can replenish all the types of cells in the blood, and are the centerpiece of transplantation as treatment for diseases such as multiple myeloma or leukemia. More

Hopkins study proves hydrogen peroxide vaporizers highly effective
Occupational Health & Safety    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Infection control experts at The Johns Hopkins Hospital report their study of the use of hydrogen peroxide vaporizers shows the devices are highly effective at killing and preventing the spread of multi-drug-resistant bacteria. These robot-like devices first were used in Singapore hospitals during the 2002 outbreak of SARS (severe acute respiratory syndrome) and later were stocked by several U.S. government agencies in case of an anthrax attack, according to the researchers, whose study is published in the journal Clinical Infectious Diseases. More

T cell 'atlas' paves way for new vaccines
Futurity    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The first-ever "atlas" of immune cells in the human body may lead to new vaccine strategies and immunotherapies. Researchers say the atlas, which they created by analyzing tissues harvested from organ donors, could provide a unique view of the distribution and function of T lymphocytes in healthy individuals. More

Knowing how cells know they aren't upside down may help fight cancer
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The tops and bottoms of cells do different jobs, and healthy organs and tissue contain well-organized cells that are the right way up. One of the first signs of cancer is when cells become disorganized and can end up upside down. Now researchers in the U.K. have discovered how cells know when they are the right way up, and suggest this knowledge will help in the fight against cancer. More

New study exposes living cells to synthetic protein
Arizona State University via Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One approach to understanding components in living organisms is to attempt to create them artificially, using principles of chemistry, engineering and genetics. A suite of powerful techniques — collectively referred to as synthetic biology — have been used to produce self-replicating molecules, artificial pathways in living systems and organisms bearing synthetic genomes. More

Lawsuit: Mom's pregnancy drug caused breast cancer in 4 daughters
CBS News and The Associated Press    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Melnick sisters thought it was just a cruel coincidence that two of them were diagnosed with breast cancer. But when two more sisters were given the same diagnosis, they came to suspect that a drug their mother took in the 1950s while she was pregnant had something to do with it. The four sisters are now suing Eli Lilly and Co., the former maker of DES (or diethylstilbestrol), in a case set to unfold in federal court when it will become one of the first of scores of such claims around the U.S. to go to trial. More


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec. 26, 2012
Dec 2, 2013
Dec. 12, 2012
Nov. 28, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063